GATA6 and prostate cancer: For prostate cancer, Li et al. [88] indicated that LINC00261 promoted DKK3 transcription expression by recruiting GATA6, and DKK3 could induce cellular quiescence and inhibit tumor progression through activating the p38 MAPK signaling pathway.